Correlation Between Qs Us and Franklin Biotechnology

Can any of the company-specific risk be diversified away by investing in both Qs Us and Franklin Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qs Us and Franklin Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Qs Large Cap and Franklin Biotechnology Discovery, you can compare the effects of market volatilities on Qs Us and Franklin Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qs Us with a short position of Franklin Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qs Us and Franklin Biotechnology.

Diversification Opportunities for Qs Us and Franklin Biotechnology

0.42

Correlation Coefficient

Qs Us  Franklin Biotechnology

Very weak diversification

The 3 months correlation between LMUSX and Franklin is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Qs Large Cap and Franklin Biotechnology Discove in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Biotechnology and Qs Us is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qs Large Cap are associated (or correlated) with Franklin Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Biotechnology has no effect on the direction of Qs Us i.e., Qs Us and Franklin Biotechnology go up and down completely randomly.

Pair Corralation between Qs Us and Franklin Biotechnology

Assuming the 90 days horizon Qs Large Cap is expected to under-perform the Franklin Biotechnology. But the mutual fund apears to be less risky and, when comparing its historical volatility, Qs Large Cap is 1.16 times less risky than Franklin Biotechnology. The mutual fund trades about -0.11 of its potential returns per unit of risk. The Franklin Biotechnology Discovery is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  12,825  in Franklin Biotechnology Discovery on December 21, 2024 and sell it today you would earn a total of  217.00  from holding Franklin Biotechnology Discovery or generate 1.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Qs Large Cap  vs.  Franklin Biotechnology Discove

Qs Large Cap

Risk-Adjusted Performance

Very Weak

Over the last 90 days Qs Large Cap has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Franklin Biotechnology

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Franklin Biotechnology Discovery are ranked lower than 2 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Franklin Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Qs Us and Franklin Biotechnology

The main advantage of trading using opposite Qs Us and Franklin Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qs Us position performs unexpectedly, Franklin Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Biotechnology will offset losses from the drop in Franklin Biotechnology's long position.

The idea behind Qs Large Cap and Franklin Biotechnology Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.